DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Efficacy

Efficacy

  • Clinical Pharmacology 1: Phase 1 Studies and Early Drug Development

    Clinical Pharmacology 1: Phase 1 Studies and Early Drug Development

  • Measuring Ligand Efficacy at the Mu- Opioid Receptor Using A

    Measuring Ligand Efficacy at the Mu- Opioid Receptor Using A

  • Antimalarial Drug Efficacy and Drug Resistance: 2000–2010 WHO Library Cataloguing-In-Publication Data

    Antimalarial Drug Efficacy and Drug Resistance: 2000–2010 WHO Library Cataloguing-In-Publication Data

  • Technical Expert Group on Drug Efficacy and Response 1–2 June 2017 Room M 605, Headquarters, World Health Organization, Geneva, Switzerland

    Technical Expert Group on Drug Efficacy and Response 1–2 June 2017 Room M 605, Headquarters, World Health Organization, Geneva, Switzerland

  • Understanding Key Determinants of Drug Activity

    Understanding Key Determinants of Drug Activity

  • Pharmacokinetics and Pharmacology of Drugs Used in Children

    Pharmacokinetics and Pharmacology of Drugs Used in Children

  • Comparison of Pharmacokinetics and Efficacy of Oral and Injectable Medicine Outline

    Comparison of Pharmacokinetics and Efficacy of Oral and Injectable Medicine Outline

  • Antibiotic Resistance Threats in the United States, 2019

    Antibiotic Resistance Threats in the United States, 2019

  • Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling

    Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling

  • Drug Metabolism a Fascinating Link Between Chemistry and Biology

    Drug Metabolism a Fascinating Link Between Chemistry and Biology

  • Allosteric Antagonism of the A2A Adenosine Receptor by a Series of Bitopic Ligands

    Allosteric Antagonism of the A2A Adenosine Receptor by a Series of Bitopic Ligands

  • Drug Resistance

    Drug Resistance

  • FDA Guidance for Industry Population Pharmacokinetics

    FDA Guidance for Industry Population Pharmacokinetics

  • Pharmacogenomics and Personalized Medicine

    Pharmacogenomics and Personalized Medicine

  • Pharmacomicrobiomics: a Novel Route Towards Personalized Medicine? Protein & Cell, 9(5)

    Pharmacomicrobiomics: a Novel Route Towards Personalized Medicine? Protein & Cell, 9(5)

  • ANTIMICROBIAL RESISTANCE Global Report on Surveillance

    ANTIMICROBIAL RESISTANCE Global Report on Surveillance

  • Cpmp/Ewp/2655/99

    Cpmp/Ewp/2655/99

  • Pharmacogenomics, a Novel Section in the European Journal of Human Genetics

    Pharmacogenomics, a Novel Section in the European Journal of Human Genetics

Top View
  • Efficacy, Toxicity, Pharmacokinetics, and in Vitro Metabolism of the Enantiomers of Ifosfamide in Mice1
  • The Concepts of Efficacy and Safety
  • Field Evaluation of Vaccine Efficacy*
  • Basic Pharmacokinetics
  • Clinical Pharmacology Section of Labeling for Human Prescription Drug and Biological Products — Content and Format
  • Predicting Drug Metabolism: Experiment And/Or Computation?
  • Drug Resistance in Bacterial Pathogens
  • Time-Dose-Fractionation in Radioimmunotherapy: Implications for Selecting Radionuclides
  • Emea/Cvmp/627/01-Final
  • Understanding the Links Between Affinity and Efficacy
  • Clinical Investigation of the Pharmacokinetics of Therapeutic Proteins
  • Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Anticancer Therapies Concetta Panebianco, Angelo Andriulli and Valerio Pazienza*
  • Session 3. Assessing Medicine Efficacy
  • Precision Medicine Goes Microscopic: Engineering the Microbiome to Improve Drug Outcomes
  • Pharmacokinetics and Pharmacodynamics of Antimicrobial Agents
  • Bacterial Resistance to Antimicrobial Agents
  • Efficacy, Tolerability, and Safety of a Novel Once-Daily Extended
  • How to Determine the Role of the Microbiome in Drug Disposition


© 2024 Docslib.org    Feedback